Team
Pipeline
Ophthalmology
Metabolic Disease
Neurology
Ophthalmology
Neurology
Metabolic Disease
Newsroom
Careers
Newsroom
Search
Search
August 4, 2020
Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
: Kriya Therapeutics Announces the Establishment of its Internal Manufacturing Facility for Process Development and Scalable cGMP Production of Gene Therapies for Prevalent Serious Diseases
May 12, 2020
Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases
: Kriya Therapeutics Announces $80 Million Series A Financing to Advance Gene Therapies for Highly Prevalent Serious Diseases
Previous
1
2
3